Menu menu
  • Flux RSS
  • Twitter
  • Facebook
  • Google Plus
  • LinkedIn
  • YouTube

Press releases

Global Bioenergies receives three additional (...)

2018

Global Bioenergies (Euronext Growth : ALGBE) announces today having been selected in three additional Horizon 2020 projects funded by the European Union, and will receive for this purpose about €2m in grants over 4 years. These projects reinforce Global Bioenergies’ strategy of feedstock diversification in order to continue improving the economics and the environmental impact of its Isobutene (...)

  • Lire la suite
  • Articles similaires

European grant amounting to €13.9 million, of which (...)

2018

Global Bioenergies today announces the start of a 3-year project to demonstrate a new value chain combining its Isobutene process with technologies developed by Sekab and Neste Engineering Solutions, two of Europe’s leading technology developers. The aim is to convert currently poorly valorised softwood residues into second generation renewable isobutene for subsequent conversion into gasoline and jetfuel. A €13.9m grant agreement was signed with INEA on behalf of the European (...)

  • Lire la suite
  • Articles similaires

IntegraGen Achieves ISO 13485:2016 Certification (...)

2018

IntegraGen (FR0010908723 : ALINT - PEA-SME Eligible) (Paris:ALINT), a company specializing in the decoding of the human genome with a focus on producing interpretable genomic analyzes for academic and private laboratories and developing diagnostic tools in oncology, today announced that it has earned ISO 13485:2016 certification from Bureau Veritas. This certification indicates that the company’s quality management systems meet the specific standards required for the design, development, (...)

  • Lire la suite
  • Articles similaires

Global Bioenergies and SkyNRG announce their (...)

2018

Global Bioenergies (GBE), the company developing a breakthrough process converting renewable resources into isobutene, and SkyNRG, world market leader in sustainable aviation fuel (SAF), will work together to accelerate the commercialization of Global Bioenergies’ approach to process isobutene into a jet fuel blending component. The companies will work towards the aviation industry’s approval allowing addition of Global Bioenergies’ isobutene-based SAF into ASTM D7566, the predominant jet fuel (...)

  • Lire la suite
  • Articles similaires

PEP-Therapy, Institut Curie and Gustave Roussy (...)

2018

PEP-Therapy, Institut Curie and Gustave Roussy join together to conduct the Clever-Peptide project. It aims at the development of an innovative anti-cancer peptide, firstly for the treatment of triple-negative breast cancer, and its companion biomarker, predictive of treatment efficacy. Approved by the Medicen Paris Region cluster, this collaborative project obtains 2,9 M€ (...)

  • Lire la suite
  • Articles similaires

Key Milestone reached in the Audi – Global (...)

2018

Global Bioenergies (Euronext Growth : ALGBE) and German carmaker Audi today announced that a key milestone was reached in their multi-year agreement. Renewable gasoline components were produced and shipped to Audi. Using its Leuna Demo plant, Global Bioenergies has produced high-purity renewable isobutene, which was further converted by the Fraunhofer Institute into high-performance gasoline additives including isooctane, ETBE and isododecane. These e-fuels will be used in engine testing (...)

  • Lire la suite
  • Articles similaires

Texcell Expands Its Commercial Presence in (...)

2018

TEXCELL, announces the opening of its subsidiary in Japan to offer a viral security services solution to biotechs and pharmaceutical industries in Japan. Bernard PLICHON, Chairman and CEO (chief executive officer) of the TEXCELL group : “After expanding its viral safety activities in the United States, with TEXCELL-NA (TEXCELL North America), in a new unit in Frederick (Maryland) in 2012, and in 2016 in Europe with the acquisition of VivoScience in Germany, TEXCELL is now expanding its (...)

  • Lire la suite
  • Articles similaires

IntegraGen and Twist Bioscience Expand Partnership (...)

2018

IntegraGen (FR0010908723 : ALINT - PEA-SME Eligible), a company specializing in the decoding of the human genome, today announced a global distribution agreement with Twist Bioscience for IntegraGen’s portfolio of genomic data analysis tools. The agreement includes distribution rights for SIRIUS™, an online Big Data solution that assists researchers to quickly and intuitively analyze exome data for Mendelian and oncology applications, and MERCURY™, an online biological interpretation tool for (...)

  • Lire la suite
  • Articles similaires

IntegraGen Partners with Twist Bioscience and (...)

2018

IntegraGen (FR0010908723 : ALINT - PEA-SME Eligible), a company specializing in the decoding of the human genome with a focus on producing interpretable genomic analyses for academic and private laboratories in addition to developing diagnostic tools in oncology, today announced the addition of Twist Bioscience Corporation’s Human Core Exome Complete Kit, a streamlined library prep and exome enrichment solution, to its next-generation targeted sequencing product (...)

  • Lire la suite
  • Articles similaires

Butagaz and Global Bioenergies present the first (...)

2018

Butagaz, one of the leading multi-energy companies in France, and Global Bioenergies present a preview of their first bottles containing bio-isobutene, a bio-sourced gas. The supply of this bio-sourced gas, which will be distributed for the first time in France in an Intermarché point of sale, is a first and decisive step towards furthering the aim of contributing to meeting France’s greenhouse gas emissions reduction target by driving innovation. Incorporating bio-isobutene in Butagaz’s (...)

  • Lire la suite
  • Articles similaires